“Pharmacoeconomic aspects of warfarin and new oral anticoagulants use as prevention of thromboembolic complications in patients with atrial fibrillation” (2020) Ukrainian Journal of Cardiology, 27(4), pp. 45–53. doi:10.31928/1608-635X-2020.4.4553.